Modern Cns Drug Discovery Reinventing the Treatment of Psychiatric and Neurological Disorders (Pb 2021) at Meripustak

Modern Cns Drug Discovery Reinventing the Treatment of Psychiatric and Neurological Disorders (Pb 2021)

Books from same Author: Schreiber R

Books from same Publisher: Springer

Related Category: Author List / Publisher List


  • Retail Price: ₹ 5516/- [ 5.00% off ]

    Seller Price: ₹ 5240

Sold By: T K Pandey      Click for Bulk Order

Offer 1: Get ₹ 111 extra discount on minimum ₹ 500 [Use Code: Bharat]

Offer 2: Get 5.00 % + Flat ₹ 100 discount on shopping of ₹ 1500 [Use Code: IND100]

Offer 3: Get 5.00 % + Flat ₹ 300 discount on shopping of ₹ 5000 [Use Code: MPSTK300]

Free Shipping (for orders above ₹ 499) *T&C apply.

In Stock

Free Shipping Available



Click for International Orders
  • Provide Fastest Delivery

  • 100% Original Guaranteed
  • General Information  
    Author(s)Schreiber R
    PublisherSpringer
    ISBN9783030623531
    Pages283
    BindingPaperback
    LanguageEnglish
    Publish YearJuly 2022

    Description

    Springer Modern Cns Drug Discovery Reinventing the Treatment of Psychiatric and Neurological Disorders (Pb 2021) by Schreiber R

    This textbook provides a comprehensive overview of the currently used concepts, approaches and technologies in the discovery and development of new treatments for the full spectrum of disorders of the central nervous system. It guides the reader through all essential steps, from finding an innovative idea, to the registration of a new drug.Divided into four sections, the book starts by presenting a broad perspective on current approaches in central nervous system (CNS) drug discovery. The second section addresses the generation of ideas for the identification of targets and novel treatment strategies; covers core functions in early discovery, and provides an example of a novel treatment paradigm: brain stimulation. The third section highlights strategies and technologies in translational CNS drug discovery. In an effort to bridge the gap between discovery and clinical development, it also covers brain imaging, EEG and cognitive testing approaches. The fourth section extensively discusses the clinical phase of drug development, covering the basics of early clinical testing for psychopharmacological drugs. The book's final chapter addresses the registration for newly developed drugs.Written by experts from academia and industry, the book covers important basics and best practices, as well as recent developments in drug discovery. Offering in-depth insights into the world of drug development, it represents essential reading for early researchers who want to prepare for a career in drug discovery in academia or industry.show more